IVIg in the chronic management of myasthenia gravis: is it enough for your money?
J Neurol Sci
.
2014 Mar 15;338(1-2):1-2.
doi: 10.1016/j.jns.2013.12.034.
Epub 2013 Dec 27.
Author
Marinos C Dalakas
1
Affiliation
1
University of Athens Medical SchoolAthens, Greece; Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: mdalakas@med.uoa.gr.
PMID:
24411405
DOI:
10.1016/j.jns.2013.12.034
No abstract available
Publication types
Editorial
Comment
MeSH terms
Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Male
Myasthenia Gravis / immunology*
Myasthenia Gravis / therapy*
Substances
Immunoglobulins, Intravenous